Synergetics USA, Inc. (SURG) Reports In-Line Q4 EPS, Sales Rose 21% Y/Y
Synergetics USA, Inc. (NASDAQ: SURG) reported Q4 EPS of $0.08, in-line with the analyst estimate of $0.08. Revenue for the quarter came in at $15.8 million versus the consensus estimate of $15.85 million.